Al-'Aqar Healthcare REIT (KLSE:ALAQAR)
Malaysia · Delayed Price · Currency is MYR 1.160
-0.010 (-0.85%)
At close: Aug 28, 2026
Al-'Aqar Healthcare REIT Balance Sheet
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Property, Plant & Equipment | 1,883 | 1,879 | 1,654 | 1,643 | 1,721 | 1,538 |
Cash & Equivalents | 43.67 | 101.5 | 87.31 | 84.33 | 96.13 | 49.34 |
Accounts Receivable | 54.66 | 52.7 | 50.68 | 51.37 | 49.5 | 36.11 |
Other Receivables | 4.28 | 0.12 | 0.25 | 0.04 | 0.08 | 0.07 |
Other Current Assets | 111.08 | 54.04 | 43.29 | 77.03 | 0.07 | 41.01 |
Total Assets | 2,097 | 2,088 | 1,836 | 1,856 | 1,867 | 1,665 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Current Portion of Long-Term Debt | 639.2 | 638.43 | 109.92 | 79.87 | - | - |
Long-Term Debt | 370.84 | 370.63 | 649.22 | 677.88 | 855.62 | 683.88 |
Accrued Expenses | - | 4.86 | 4.96 | 6.36 | 7.8 | 5.46 |
Other Current Liabilities | 13.21 | 2.55 | 0.74 | 1.68 | 15.52 | 15.15 |
Long-Term Unearned Revenue | - | 5.22 | 5.22 | 5.73 | 5.2 | 5.17 |
Long-Term Deferred Tax Liabilities | 1.32 | 1.32 | 1.32 | 1.52 | 1.66 | 1.77 |
Other Long-Term Liabilities | 20.02 | 14.8 | 11.01 | 10.65 | 10.05 | 8.3 |
Total Liabilities | 1,045 | 1,038 | 782.39 | 783.69 | 895.85 | 719.73 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 854.76 | 854.76 | 854.76 | 854.76 | 756.41 | 731.4 |
Retained Earnings | 215.09 | 213.79 | 214.92 | 221.29 | 224.36 | 221.63 |
Comprehensive Income & Other | -17.39 | -18.75 | -16.13 | -3.75 | -9.55 | -8.02 |
Shareholders' Equity | 1,052 | 1,050 | 1,054 | 1,072 | 971.21 | 945 |
Total Liabilities & Equity | 2,097 | 2,088 | 1,836 | 1,856 | 1,867 | 1,665 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,010 | 1,009 | 759.14 | 757.75 | 855.62 | 683.88 |
Net Cash (Debt) | -966.38 | -907.55 | -671.83 | -673.42 | -759.49 | -634.54 |
Net Cash (Debt) Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.15 | -1.08 | -0.80 | -0.83 | -1.03 | -0.86 |
Filing Date Shares Outstanding | 839.6 | 839.6 | 839.6 | 839.6 | 756.49 | 735.99 |
Total Common Shares Outstanding | 839.6 | 839.6 | 839.6 | 839.6 | 756.49 | 735.99 |
Book Value Per Share | 1.25 | 1.25 | 1.25 | 1.28 | 1.28 | 1.28 |
Tangible Book Value | 1,052 | 1,050 | 1,054 | 1,072 | 971.21 | 945 |
Tangible Book Value Per Share | 1.25 | 1.25 | 1.25 | 1.28 | 1.28 | 1.28 |